Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 1994

Primary Completion Date

December 31, 2000

Study Completion Date

December 31, 2000

Conditions

Breast Cancer

Interventions

BIOLOGICAL

filgrastim

DRUG

cyclophosphamide

DRUG

megestrol acetate

DRUG

melphalan

DRUG

tamoxifen citrate

DRUG

thiotepa

PROCEDURE

conventional surgery

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

Trial Locations (1)

Yale Comprehensive Cancer Center, New Haven

All Listed Sponsors

lead

Yale University

OTHER